Mr. Eugene Jiang, MBA, is a managing director of BioLite Japan. He is also the chairman and founder of American BriVision (Holding) Corporation, which is a biotechnology company currently listed on the NASDAQ in the U.S.A. (Stock symbol: ABVC), focusing on the translational medical research of new drugs and innovative medical devices. Mr. Jiang has brought a joint venture to Japan to work with academics through BioLite Japan’s unique translational and clinical research capability together with VC component. He received his EMBA degree from the University of Texas at Arlington and his PMBA degree from the National Taiwan University.